Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1657 | 2 | FEBRILE NEUTROPENIA//METASTATIC BREAST CANCER//NEUTROPENIA | 7171 |
11908 | 1 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM | 973 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PEGFILGRASTIM | authKW | 4145837 | 16% | 80% | 160 |
2 | FEBRILE NEUTROPENIA | authKW | 1708895 | 21% | 25% | 207 |
3 | FILGRASTIM | authKW | 1396295 | 12% | 36% | 120 |
4 | CHEMOTHERAPY INDUCED NEUTROPENIA | authKW | 529011 | 3% | 58% | 28 |
5 | NEUTROPENIA | authKW | 488718 | 21% | 8% | 200 |
6 | GRANULOCYTE COLONY STIMULATING FACTOR | authKW | 396936 | 14% | 9% | 138 |
7 | LIPEGFILGRASTIM | authKW | 291509 | 1% | 100% | 9 |
8 | G CSF | authKW | 253576 | 12% | 7% | 118 |
9 | RELATIVE DOSE INTENSITY | authKW | 182174 | 2% | 38% | 15 |
10 | LENOGRASTIM | authKW | 177845 | 2% | 31% | 18 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 14699 | 63% | 0% | 614 |
2 | Health Care Sciences & Services | 3667 | 14% | 0% | 132 |
3 | Hematology | 2709 | 17% | 0% | 161 |
4 | Rehabilitation | 1666 | 9% | 0% | 87 |
5 | Pharmacology & Pharmacy | 608 | 17% | 0% | 162 |
6 | Nursing | 486 | 4% | 0% | 43 |
7 | Health Policy & Services | 283 | 3% | 0% | 30 |
8 | Medicine, General & Internal | 119 | 7% | 0% | 66 |
9 | Transplantation | 98 | 2% | 0% | 24 |
10 | Medicine, Research & Experimental | 38 | 4% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HLTH SERV OUTCOMES PROGRAM | 97170 | 0% | 100% | 3 |
2 | ECPM EXECUT OFF | 72876 | 0% | 75% | 3 |
3 | TEVA RATIOPHARM | 72876 | 0% | 75% | 3 |
4 | ONCOL MASTERS PROGRAM | 64780 | 0% | 100% | 2 |
5 | ONCOLSEVERANCE HOSP | 64780 | 0% | 100% | 2 |
6 | GBG FOR GMBH | 58299 | 0% | 60% | 3 |
7 | HUTCHINSON CANC OUTCOMES | 45219 | 1% | 16% | 9 |
8 | BMT CORD BLOOD BANK | 43185 | 0% | 67% | 2 |
9 | EUROPEAN PHARMACEUT MED | 41754 | 1% | 18% | 7 |
10 | GLOBAL BIOSTAT SCI | 37464 | 1% | 13% | 9 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SUPPORTIVE CARE IN CANCER | 41471 | 8% | 2% | 76 |
2 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 6590 | 2% | 1% | 21 |
3 | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 4711 | 1% | 1% | 12 |
4 | ONCOLOGY NURSING FORUM | 4407 | 1% | 1% | 11 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 4294 | 5% | 0% | 47 |
6 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 4259 | 1% | 2% | 6 |
7 | ANNALS OF ONCOLOGY | 3635 | 3% | 0% | 31 |
8 | CURRENT ONCOLOGY | 3489 | 1% | 1% | 10 |
9 | BIODRUGS | 3137 | 1% | 1% | 10 |
10 | CLINICAL JOURNAL OF ONCOLOGY NURSING | 3036 | 1% | 1% | 9 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEGFILGRASTIM | 4145837 | 16% | 80% | 160 | Search PEGFILGRASTIM | Search PEGFILGRASTIM |
2 | FEBRILE NEUTROPENIA | 1708895 | 21% | 25% | 207 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
3 | FILGRASTIM | 1396295 | 12% | 36% | 120 | Search FILGRASTIM | Search FILGRASTIM |
4 | CHEMOTHERAPY INDUCED NEUTROPENIA | 529011 | 3% | 58% | 28 | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA |
5 | NEUTROPENIA | 488718 | 21% | 8% | 200 | Search NEUTROPENIA | Search NEUTROPENIA |
6 | GRANULOCYTE COLONY STIMULATING FACTOR | 396936 | 14% | 9% | 138 | Search GRANULOCYTE+COLONY+STIMULATING+FACTOR | Search GRANULOCYTE+COLONY+STIMULATING+FACTOR |
7 | LIPEGFILGRASTIM | 291509 | 1% | 100% | 9 | Search LIPEGFILGRASTIM | Search LIPEGFILGRASTIM |
8 | G CSF | 253576 | 12% | 7% | 118 | Search G+CSF | Search G+CSF |
9 | RELATIVE DOSE INTENSITY | 182174 | 2% | 38% | 15 | Search RELATIVE+DOSE+INTENSITY | Search RELATIVE+DOSE+INTENSITY |
10 | LENOGRASTIM | 177845 | 2% | 31% | 18 | Search LENOGRASTIM | Search LENOGRASTIM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |